ScripsAmerica Featured by Leading Microcap and Emerging Growth Financial News Site

CEO Bob Schneiderman Conducts In-Depth Q&A with StockNewsNow

ScripsAmerica, Inc. (OTCBB: SCRC), a leading provider of a range of specialty prescription and over the counter pharmaceuticals and medical supplies, today announced that Bob Schneiderman, Chief Executive Officer and Founding Partner, has been featured in a one-on-one interview with StockNewsNow.com, a microcap financial news portal that features news and insights from the microcap and emerging growth financial community.

The article, which can be found here, covers the genesis of ScripsAmerica, the inception of operations in 2010, the Company’s significant growth over the past year, and its plans for 2015. Some of the topics discussed in the interview include:

Revenues in fiscal 2014 are expected to be $31.5 million as compared to less than $1 million in 2013 on the strength of the growth of the Company's Main Avenue Pharmacy business
The Company was profitable for the second half of fiscal 2014
Sustaining the momentum developed over the second half of 2014, the Company expects to be profitable in the first quarter of 2015 on revenues that are expected to be approximately $9.5 million
In addition to the opportunity for organic growth through Main Avenue Pharmacy, the Company has signed Letters of Intent to accelerate growth through the acquisition of two additional pharmacies, which will extend the Company's licenses from 10 states to 40 states
In addition to Main Avenue Pharmacy, ScripsAmerica has growing revenue streams in Diabetic Medical Supplies and Wholesale Pharmaceutical Sales
Over the course of 2014, the Company’s working capital position improved by overall $3 million, which has been subsequently supplemented with a $4 million Line of Credit with a subsidiary of a large commercial bank

The interview also includes a discussion on ScripsAmerica’s evolving markets as well as its overall business strategy.

ScripsAmerica was previously featured on SNNLive in November 2014.

About ScripsAmerica, Inc.

ScripsAmerica, Inc. is a supplier of prescription, OTC and nutraceutical drugs, delivering pharmaceutical products to a wide range of end users across the health care industry. End users include retail pharmacies, hospitals, long-term care facilities and government and home care agencies. For more information, visit www.ScripsAmerica.com.

Safe Harbor Statement

This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether a result of new information, future events or otherwise.

Gregory FCAJoe Hassett, 610-228-2110joeh@gregoryfca.com

ScripsAmerica (CE) (USOTC:SCRCQ)
過去株価チャート
から 11 2024 まで 12 2024